Cross-source evidence timeline

Dasiglucagon research timeline

Follow 20 selected, directly cited source records from April 21, 2017 through November 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

20Selected records
8Source years
3Evidence lanes
November 9, 2026Latest source date

Source year

2026

3 records
  1. Literature metadata

    Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.↗

    PubMed lists PMID 33906916 in Diabetes care as Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-04-27 (day precision). PeptideScanner associated the retained record with the identity slug dasiglucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Dasiglucagon Hydrochloride.↗

    PubMed lists PMID 33998648 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2021-07-22 (day precision). PeptideScanner associated the retained record with the identity slug dasiglucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03941236↗

    PeptideScanner retained ClinicalTrials.gov record NCT03941236 at 2026-11-16T01:42:39.027Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

Source year

2025

2 records
  1. Clinical trials

    ClinicalTrials.gov record NCT05378672↗

    PeptideScanner retained ClinicalTrials.gov record NCT05378672 at 2026-11-16T01:42:39.027Z. Its registry update date was 2025-07-20, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT04172441↗

    PeptideScanner retained ClinicalTrials.gov record NCT04172441 at 2026-11-16T01:42:39.027Z. Its registry update date was 2025-03-14, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

Source year

2023

4 records
  1. Clinical trials

    ClinicalTrials.gov record NCT03777176↗

    PeptideScanner retained ClinicalTrials.gov record NCT03777176 at 2026-11-16T01:42:39.027Z. Its registry update date was 2023-12-13, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

  2. Regulatory

    Federal Register notice 2023-26260↗

    The Federal Register published notice 2023-26260, attributed to FDA and its parent HHS department, on 2023-11-30. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; ZEGALOGUE,” and PeptideScanner's exact reviewed identity mapping connects the document to Dasiglucagon.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03895697↗

    PeptideScanner retained ClinicalTrials.gov record NCT03895697 at 2026-11-16T01:42:39.027Z. Its registry update date was 2023-02-21, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT04836273↗

    PeptideScanner retained ClinicalTrials.gov record NCT04836273 at 2026-11-16T01:42:39.027Z. Its registry update date was 2023-02-02, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

Source year

2022

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT04764968↗

    PeptideScanner retained ClinicalTrials.gov record NCT04764968 at 2026-11-16T01:42:39.027Z. Its registry update date was 2022-09-07, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

Source year

2021

7 records
  1. Clinical trials

    ClinicalTrials.gov record NCT03667053↗

    PeptideScanner retained ClinicalTrials.gov record NCT03667053 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-06-30, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03378635↗

    PeptideScanner retained ClinicalTrials.gov record NCT03378635 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-06-10, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03688711↗

    PeptideScanner retained ClinicalTrials.gov record NCT03688711 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-05-19, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT03216226↗

    PeptideScanner retained ClinicalTrials.gov record NCT03216226 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-05-04, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT03735225↗

    PeptideScanner retained ClinicalTrials.gov record NCT03735225 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-03-23, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

  6. Regulatory

    Drugs@FDA application NDA214231↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 214231 with status AP dated 2021-03-22, and names dasiglucagon hydrochloride among the application record's active ingredients.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT04449692↗

    PeptideScanner retained ClinicalTrials.gov record NCT04449692 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-02-09, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

Source year

2020

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT03984370↗

    PeptideScanner retained ClinicalTrials.gov record NCT03984370 at 2026-11-16T01:42:39.027Z. Its registry update date was 2020-03-31, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

Source year

2019

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT03840278↗

    PeptideScanner retained ClinicalTrials.gov record NCT03840278 at 2026-11-16T01:42:39.027Z. Its registry update date was 2019-12-16, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗

Source year

2017

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT02916251↗

    PeptideScanner retained ClinicalTrials.gov record NCT02916251 at 2026-11-16T01:42:39.027Z. Its registry update date was 2017-04-21, and PeptideScanner's reviewed identity mapping was dasiglucagon.↗